Romiplostim for the treatment of chronic immune (idiopathic) thrombocytopenic purpura

ONCOLOGY

Volumn 23, Issue 8, 2009, Pages

  Jamali, Faranak ^a   Lemery, Steven ^a   Ayalew, Kassa ^a   Robottom, Suzanne ^a   Robie Suh, Kathy ^a   Rieves, Dwaine ^a   Pazdur, Richard ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID; IMMUNOGLOBULIN; NPLATE; PLACEBO; RETICULIN; RHESUS D ANTIBODY; ROMIPLOSTIM; UNCLASSIFIED DRUG;

ABDOMINAL PAIN; ACUTE LEUKEMIA; ADULT; AGED; ARTHRALGIA; BONE MARROW; BRAIN HEMORRHAGE; CLINICAL STUDY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA ANALYSIS; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG SAFETY; DRUG WITHDRAWAL; DYSPEPSIA; FEMALE; FOOD AND DRUG ADMINISTRATION; HEADACHE; HEMATOLOGIC MALIGNANCY; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; INSOMNIA; LIMB PAIN; MAJOR CLINICAL STUDY; MALE; MYALGIA; MYELODYSPLASTIC SYNDROME; MYELOFIBROSIS; PARESTHESIA; RANDOMIZED CONTROLLED TRIAL; RECIPIENT; REVIEW; RISK ASSESSMENT; SHOULDER PAIN; SIDE EFFECT; SPLENECTOMY; THROMBOCYTE; THROMBOCYTE COUNT; THROMBOCYTOPENIA; THROMBOEMBOLISM;

EID: 69949092807     PISSN: 08909091     EISSN: 08909091     Source Type: Journal    
DOI: None     Document Type: Review

References (9)

1. McMillan R: Chronic idiopathic thrombocytopenic purpura. N Engl J Med 304:1135-1147, 1981.
2. Cines DB, Blanchette VS: Immune thrombocytopenic purpura. N Engl J Med 346:995-1008, 2002.
3. McMillan R, Imbach P: Immune thrombocytopenic purpura, in Loscalzo J, Schafer AI (eds): Thrombosis and Hemorrhage, pp 476-495. Philadelphia, Lippincott Williams & Wilkins, 2003.
4. Rodeghiero F, Stasi R, Gernsheimer T, et al: Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: Report from an international working group. Blood 113:2386-2393, 2009.
5. Yang L, Xia Y, Glaspy J, et al: Thrombocytopenia caused by the development of antibodies to thrombopoietin. Blood 98:3241-3248, 2001.
6. Wang B, Nichol J, Sullivan J: Pharmacodynamics and pharmacokinetics of AMG 531, a novel thrombopoietin receptor ligand. Clin Pharmacol Ther 76:628-638, 2004. (Pubitemid 39601552)
7. Greenberg P, Cox C, LeBeau MM, et al: International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood 89:2079-2088, 1997. (Pubitemid 27132124)
8. Vignon I, Dreyfus F, Melle J, et al: Expression of the c-mpl proto-oncogene in human hematologic malignancies. Blood 82: 877-883, 1993. (Pubitemid 23221669)
9. Matsumura I, Kanakura Y, Kato T, et al: Growth response of acute myeloblastic leukemia cells to recombinant human thrombopoietin. Blood 86:703-709, 1995.